Core Scientific supplements proxy statement with director RSU values and DCF details to address merger lawsuits

Core Scientific, Inc./tx

Three stockholder lawsuits (CT and NY) and demands alleged proxy deficiencies; Core Scientific and CoreWeave deny merit but voluntarily supplement.
Supplemental disclosure: aggregate unvested RSU value for non-employee directors is $8,515,576, with individual amounts up to $1,972,906.
Moelis updated comparable company analysis tables; PJT Partners provided DCF discount rates and terminal value multiples for Core Scientific and CoreWeave.
No change to merger terms; supplemental disclosures intended to moot litigation without admission of liability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.